Roche Unveils Newborn Screening Test For 3 Genetic Conditions Of SMA, SCID, Sickle Cell Disease

Roche launched a newborn screening test targeting three severe genetic conditions: spinal muscular atrophy (SMA), severe combined immunodeficiency disease (SCID), and sickle cell disease. The product launch expands Roche's neonatal diagnostics offering and could support earlier detection and treatment, though the article provides no financial contribution estimates or sales outlook.